Skip to main content
Chakravarthy B. Reddy
( out of 88 reviews )

Chakravarthy B. Reddy, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132

Chakravarthy Reddy, MD, is an Huntsman Cancer Institute investigator and assistant professor in the Department of Medicine at the University of Utah School of Medicine. He specializes in lung cancer, airway disorders, and malignant pleural effusion. He is interested in advancing non-surgical ways to diagnose and treat cancers that occur in the chest. He performs flexible and rigid bronchoscopy, pleuroscopy, endobronchial ultrasonography, and airway stent placements.

Reddy attended Mysore Medical College in Mysore, Karnataka, India. He completed an internship and residency at St. Barnabas Hospital in the Bronx, New York, where he also served as attending physician. He completed a fellowship in pulmonary and critical care medicine at the University of Utah School of Medicine and received additional training in interventional pulmonology medicine at Harvard Medical School.

Reddy is a certified member of the American Board of Internal Medicine, the American Association of Bronchology, the American College of Chest Physicians, and the American Thoracic Society.

Reddy volunteers and does community service locally and internationally. He has performed health care screenings in Africa and Ecuador.

Board Certification

American Association for Bronchology and Interventional Pulmonology
American Board of Internal Medicine (Sub: Pulmonary Disease)
American Board of Internal Medicine (Sub: Critical Care Medicine)

Patient Rating

4.9 /5
( out of 88 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

HUNTSMAN CANCER CENTER

I enjoyed my visit with Dr Reddy. He was very informative and explained everything

UNIVERSITY HOSPITAL

Very nice and felt respected by the doctor.

HUNTSMAN CANCER CENTER

Muy profesional

HUNTSMAN CANCER CENTER

Dr Reddy was very compassionate, honest and he listened to me. HeÕs thorough, friendly, and he gets the right tests ordered so you can get the answers you need

SOUTH JORDAN HEALTH CENTER

We are just meet this doctor is us second visit but I will tell you he is very good doctor and kind he lesson you he understands what supplies doctors should know very nice doctor

HUNTSMAN CANCER CENTER

we felt like we were being pushed to someone else and that someone else never followed up. which left us with nothing.

HUNTSMAN CANCER CENTER

Cares and seems to understand what is needed. Explains very well

HUNTSMAN CANCER CENTER

when we left my husband said no one has ever explained what they were doing and how they were going to do it and why to me so well and I'm not even the patient.

HUNTSMAN CANCER CENTER

Very good

Chakravarthy Reddy, MD, is an Huntsman Cancer Institute investigator and assistant professor in the Department of Medicine at the University of Utah School of Medicine. He specializes in lung cancer, airway disorders, and malignant pleural effusion. He is interested in advancing non-surgical ways to diagnose and treat cancers that occur in the chest. He performs flexible and rigid bronchoscopy, pleuroscopy, endobronchial ultrasonography, and airway stent placements.

Reddy attended Mysore Medical College in Mysore, Karnataka, India. He completed an internship and residency at St. Barnabas Hospital in the Bronx, New York, where he also served as attending physician. He completed a fellowship in pulmonary and critical care medicine at the University of Utah School of Medicine and received additional training in interventional pulmonology medicine at Harvard Medical School.

Reddy is a certified member of the American Board of Internal Medicine, the American Association of Bronchology, the American College of Chest Physicians, and the American Thoracic Society.

Reddy volunteers and does community service locally and internationally. He has performed health care screenings in Africa and Ecuador.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor (Clinical)
Academic Divisions Public Health
Board Certification
American Association for Bronchology and Interventional Pulmonology
American Board of Internal Medicine (Sub: Pulmonary Disease)
American Board of Internal Medicine (Sub: Critical Care Medicine)

Education history

Undergraduate S. S. Pre-University College
Professional Medical Mysore Medical College M.B.B.S.
Internship General Medicine/Surgery - Krishna Rajendra Hospital Intern
Clerkship Internal Medicine - Weill Medical College of Cornell University Clinical Clerkship
Internship Internal Medicine - St. Barnabas Hospital Intern
Residency Internal Medicine - St. Barnabas Hospital Resident
Fellowship Pulmonary/Critical Care - University of Utah School of Medicine Fellow
Fellowship Interventional Pulmonology - Harvard Medical School, Beth Israel Deaconess Medical Center Fellow
Biomedical Engineering - University of Utah MS

Selected Publications

Journal Article

  1. Shrager JB, Bhatnagar R, Kearney CT, Retzlaff NP, Cohen E, Stanton AE, Keyes C, Wahidi MM, Gillespie C, Rahman N, Kerry AL, Feller-Kopman D, Nader D, Akulian J, Chen A, Berry M, Majid A, Reddy C, Tremblay A, Maskell N (2022). Silver Nitrate-Coated Versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial. Annals of the American Thoracic Society,
  2. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy CB, Tao R, Hitchcock YJ, Kokeny KE, Salter B (2020). Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT. Medical physics, 47(9), 4407-4415.
  3. Reddy C, Ernst A, Lamb C, Feller-Kopman (2011). Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest, 139(6), 1419-1423.
  4. Reddy (2009). Bronchoprovocation testing. Clinical reviews in allergy & immunology, 37(3), 167-72.
  5. Wang H, Yuan Z, Pavel MA, Jablonski SM, Jablonski J, Hobson R, Valente S, Reddy CB, Hansen S (2023). The role of high cholesterol in SARS-CoV-2 infectivity. The Journal of biological chemistry, 104763.
  6. Raza HA, Raja MHR, Chambers JH, Reddy CB, Shafiq (2023). Bronchoscopic Management of Hemoptysis Caused by Airway Erosion From Vascular Coils. Journal of bronchology & interventional pulmonology,
  7. Reddy C, Sethi J, Balwan A, Iravani A, Ansari S, Kelly (2023). Aerosol Generation During Bronchoscopy. Journal of bronchology & interventional pulmonology, 30(1), 7-15.
  8. Akulian J, Bedawi EO, Abbas H, Argento C, Arnold DT, Balwan A, Batra H, Uribe Becerra JP, Belanger A, Berger K, Burks AC, Chang J, Chrissian AA, DiBardino DM, Fuentes XF, Gesthalter YB, Gilbert CR, Glisinski K, Godfrey M, Gorden JA, Grosu H, Gupta M, Kheir F, Ma KC, Majid A, Maldonado F, Maskell NA, Mehta H, Mercer J, Mullon J, Nelson D, Nguyen E, Pickering EM, Puchalski J, Reddy C, Revelo AE, Roller L, Sachdeva A, Sanchez T, Sathyanarayan P, Semaan R, Senitko M, Shojaee S, Story R, Thiboutot J, Wahidi M, Wilshire CL, Yu D, Zouk A, Rahman NM, Yarmus L, Interventional Pulmonary Outcomes Grou (2022). Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study. Chest, 162(6), 1384-1392.
  9. Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen S (2022). Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Communications biology, 5(1), 958.
  10. Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes (2022). NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. Journal of the National Comprehensive Cancer Network, 20(7), 754-764.
  11. Lee HJ, Argento AC, Batra H, Benzaquen S, Bramley K, Chambers D, Desai N, Dincer HE, Ferguson JS, Kalanjeri S, Lamb C, Meena N, Reddy C, Revelo A, Sachdeva A, Seides B, Shah H, Shojaee S, Sonetti D, Thiboutot J, Toth J, Van Nostrand K, Akulian J (2022). A Multicenter Study Assessing Interventional Pulmonary Fellow Competency in Electromagnetic Navigation Bronchoscopy. ATS scholar, 3(2), 220-228.

Review

  1. Reddy C, Chilla D, Boltax (2011). Lung cancer screening: a review of available data and current guidelines. Hospital practice (1995), 39(4), 107-12.

Letter

  1. Iravani A, Reddy (2022). Use of Self-expanding Metallic Y Stent in the United States: First Report. Journal of bronchology & interventional pulmonology, 29(2), e23-e25.

Other

  1. Wang H, Yuan Z, Pavel MA, Jablonski SM, Jablonski J, Hobson R, Valente S, Reddy CB, Hansen S (2021). The role of high cholesterol in age-related COVID19 lethality.
  2. Wilshire CL, Chang SC, Gilbert CR, Akulian JA, AlSarraj MK, Asciak R, Bevill BT, Davidson KR, Delgado A, Grosu HB, Herth FJF, Lee HJ, Lewis JE, Maldonado F, Ost DE, Pastis NJ, Rahman NM, Reddy CB, Roller LJ, Sanchez TM, Shojaee S, Steer H, Thiboutot J, Wahidi MM, Wright AN, Yarmus LB, Gorden J (2021). Temporal Trends in Tunneled Pleural Catheter Utilization in Patients With Malignancy: A Multicenter Review. Chest, 159(6), 2483-2487.
  3. Wilshire CL, Chang SC, Gilbert CR, Akulian JA, AlSarraj MK, Asciak R, Bevill BT, Davidson KR, Delgado A, Grosu HB, Herth FJF, Lee HJ, Lewis JE, Maldonado F, Ost DE, Pastis NJ, Rahman NM, Reddy CB, Roller LJ, Sanchez TM, Shojaee S, Steer H, Thiboutot J, Wahidi MM, Wright AN, Yarmus LB, Gorden J (2021). Association between Tunneled Pleural Catheter Use and Infection in Patients Immunosuppressed from Antineoplastic Therapy. A Multicenter Study. Annals of the American Thoracic Society, 18(4), 606-612.
  4. Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel (2019). Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. American journal of respiratory and critical care medicine, 200(11), 1354-1362.
  5. Grosu HB, Molina S, Casal R, Song J, Li L, Diaz-Mendoza J, Reddy C, Yarmus L, Schiavo D, Simoff M, Johnstun J, Raid AA, Feller-Kopman D, Lee H, Sahetya S, Foley F, Maldonado F, Tian X, Noor L, Miller R, Mudambi L, Saettele T, Vial-Rodriguez M, Eapen GA, Ost D (2019). Risk factors for pleural effusion recurrence in patients with malignancy. Respirology (Carlton, Vic.), 24(1), 76-82.
  6. Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M, National comprehension cancer network (2015). Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network, 13(1), 23-34; quiz 34.
  7. Yuan Z, Pavel MA, Wang H, Kwachukwu JC, Mediouni S, Jablonski JA, Nettles KW, Reddy CB, Valente ST, Hansen S (2022). Author Correction: Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture. Communications biology, 5(1), 1164.